Your browser doesn't support javascript.
Why scientists are racing to develop more COVID antivirals.
Nature ; 601(7894): 496, 2022 01.
Article in English | MEDLINE | ID: covidwho-1641925
Subject(s)
Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; COVID-19/virology; Drug Development/trends; Drug Resistance, Viral; Research Personnel; SARS-CoV-2/drug effects; Adenosine Monophosphate/administration & dosage; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/pharmacology; Adenosine Monophosphate/therapeutic use; Administration, Oral; Alanine/administration & dosage; Alanine/analogs & derivatives; Alanine/pharmacology; Alanine/therapeutic use; Antiviral Agents/administration & dosage; Antiviral Agents/pharmacology; Antiviral Agents/supply & distribution; COVID-19/mortality; COVID-19/prevention & control; COVID-19 Vaccines/supply & distribution; Cytidine/administration & dosage; Cytidine/analogs & derivatives; Cytidine/pharmacology; Cytidine/therapeutic use; Drug Approval; Drug Combinations; Drug Resistance, Viral/drug effects; Drug Resistance, Viral/genetics; Drug Therapy, Combination; Hospitalization/statistics & numerical data; Humans; Hydroxylamines/administration & dosage; Hydroxylamines/pharmacology; Hydroxylamines/therapeutic use; Lactams/administration & dosage; Lactams/pharmacology; Lactams/therapeutic use; Leucine/administration & dosage; Leucine/pharmacology; Leucine/therapeutic use; Medication Adherence; Molecular Targeted Therapy; Mutagenesis; Nitriles/administration & dosage; Nitriles/pharmacology; Nitriles/therapeutic use; Proline/administration & dosage; Proline/pharmacology; Proline/therapeutic use; Public-Private Sector Partnerships/economics; Ritonavir/administration & dosage; Ritonavir/pharmacology; Ritonavir/therapeutic use; SARS-CoV-2/enzymology; SARS-CoV-2/genetics
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Research Personnel / Drug Resistance, Viral / Drug Development / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Nature Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Research Personnel / Drug Resistance, Viral / Drug Development / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Nature Year: 2022 Document Type: Article